The diagnostic accuracy of adiponectin for MetS has been confirmed in a Korean population [17,18], but the adoption of this new supplementary blood test in routine health checkups has lacked sufficient evidence to prove additional benefits on top of the current blood tests, which include glucose, HDL-C, and triglycerides. The gene discussed is ADIPOQ; the disease is metabolic syndrome.